|
| | Issue Date | Title | Contributor(s) | Type | Cat. |
| 1 | 2024 | Cancer therapy-related vaginal toxicity: its prevalence and assessment methods-a systematic review | CLAES, Marithe; Tuts, L.; ROBIJNS, Jolien; Mulders, K.; van de Werf, E.; BULENS, Paul; MEBIS, Jeroen | Journal Contribution | A1 |
| 2 | 2024 | Pyridoxamine Limits Cardiac Dysfunction in a Rat Model of Doxorubicin-Induced Cardiotoxicity | HAESEN, Sibren; JAGER, Manon Marie; Brillouet, Aline; DE LAAT, Iris; VASTMANS, Lotte; VERGHOTE, Eline; DELAET, Anouck; D'HAESE, Sarah; HAMAD, Ibrahim; KLEINEWIETFELD, Markus; MEBIS, Jeroen; MULLENS, Wilfried; LAMBRICHTS, Ivo; WOLFS, Esther; DELUYKER, Dorien; BITO, Virginie | Journal Contribution | A1 |
| 3 | 2023 | Steroid-dependent pericarditis following anti-PD1 immunotherapy in a metastatic melanoma patient: a case report | Verhaert, Marthe; MEBIS, Jeroen; Aspeslagh, Sandrine; von Kemp, Berlinde; Rossi, Valentina; Komorovsky, Roman; Gambaro, Alessia; Kovacs, Boldizsar; Peverelli, Marta; Jathanna, Nikesh | Journal Contribution | A1 |
| 4 | 2023 | Afatinib for EGFR, HER2 or HER3 mutated solid tumors: A phase II Belgian precision study | Decoster, L.; Aftimos, P. G.; Rottey, S.; Prenen, H.; Collignon, J. J.; MEBIS, Jeroen; Canon, J-L.; Fastenaekels, V.; Cappoen, N.; Joris, S. R.; De Greve, J. | Journal Contribution | M |
| 5 | 2023 | GeNeo: Agnostic comprehensive genomic profiling versus limited panel organ-directed next-generation sequencing within the Belgian PRECISION initiative | Aftimos, P. G.; Punie, K.; Decoster, L.; de Lummen, C. Van Marcke; Hebrant, A.; Raicevic, G.; Van Valckenborgh, E.; MAES, Brigitte; Maetens, J.; Collignon, J. J.; van den Mooter, T. F. A.; Fried-Vermeij, J.; Demey, W.; Tejpar, S.; Peeters, M.; Canon, J-L.; Lybaert, W.; MEBIS, Jeroen; Rottey, S.; De Greve, J. | Journal Contribution | M |
| 6 | 2023 | Efficacy of olaparib in advanced cancers with germline or somatic tumor mutations in BRCA1, BRCA2, CHEK2 and ATM: A Belgian precision tumor-agnostic phase II study | Joris, S. R.; Denys, H.; Collignon, J. J.; Rasschaert, M.; de Roodenbeke, D. T'Kint; Duhoux, F. P.; Canon, J-L.; Tejpar, S.; MEBIS, Jeroen; Decoster, L.; Aftimos, P. G.; De Greve, J. | Journal Contribution | M |
| 7 | 2023 | The use of photobiomodulation therapy for the management of chemotherapy-induced alopecia: a randomized, controlled trial (HAIRLASER trial) | LODEWIJCKX, Joy; ROBIJNS, Jolien; CLAES, Marithe; Pierson, Maud; Lenaerts, Melissa; MEBIS, Jeroen | Journal Contribution | A1 |
| 8 | 2023 | Evaluation of a novel skin care product for the management of chemotherapy– related dermatologic toxicities: A quasi-experimental study | ROBIJNS, Jolien; LODEWIJCKX, Joy; CLAES, Marithe; Tuts, Laura; Lenaerts, Melissa; Wessels, Tim; Requilé, Annelies; Luyten, Daisy; Verheezen, Jolanda; Joosens, Eric; MEBIS, Jeroen | Journal Contribution | A1 |
| 9 | 2023 | Photobiomodulation in the management of chemotherapy-induced peripheral neuropathy: a randomized, controlled trial | CLAES, Marithe; LODEWIJCKX, Joy; Hermans, S.; Peeters, P.; MEBIS, Jeroen; ROBIJNS, Jolien | Journal Contribution | M |
| 10 | 2023 | A novel, multi-active emollient for the prevention of acute radiation dermatitis in breast cancer patients: a randomized clinical trial | ROBIJNS, Jolien; Van Bever, Leen; Hermans, Sanne; CLAES, Marithe; LODEWIJCKX, Joy; Lenaerts, Melissa; Tuts, Laura; Vandaele, Eline; Vinken, Evelien; Noé, Leen; Verboven, Katleen; MAES, Annelies; Van de Velde, Anne-Sophie; BULENS, Paul; Bulens, Philippe; Van den Bergh, Laura; MEBIS, Jeroen | Journal Contribution | A1 |
| 11 | 2022 | Prospective non-interventional BELOVA/BGOG-ov16 study on safety of frontline bevacizumab in elderly patients with FIGO stage IV ovarian cancer: a study of the Belgian and Luxembourg Gynaecological Oncology Group | Vergote, I; Van Nieuwenhuysen, E; De Waele, S; Vulsteke, C; Lamot, C; Van den Bulck, H; CLAES, Nele; Graas, MP; DEBROCK, Guy; Spoormans, I; Vuylsteke, P; Honhon, B; Verhoeven, D; Daan De Maeseneer; Dirix, L; MEBIS, Jeroen; Vroman, P; Denys, H; Mena, CM; Pelgrims, G; Van Steenberghe, M; van Gorp, T; Gennigens, C | Journal Contribution | A1 |
| 12 | 2022 | PRECISION: the Belgian molecular profiling program of metastatic cancer for clinical decision and treatment assignment | Thouvenin, J.; Van Marcke, C.; Decoster, L.; Raicevic, G.; Punie, K.; Vandenbulcke, M.; Salgado, R.; Van Valckenborgh, E.; Maes, B.; Joris, S.; Vander Steichel, D.; Vranken, K.; Jacobs , S.; Dedeurwaerdere, F.; Martens, G.; Devos, H.; Duhoux, F. P.; Rasschaert, M.; Pauwels , P.; Geboes, K.; Collignon, J.; Tejpar, S.; Canon, J-L; Peeters, M.; Rutten, A.; Van de Mooter, T.; Vermeij, J.; Schrijvers, D.; Demey, W.; Lybaert, W.; Van Huysse, J.; MEBIS, Jeroen; Awada, A.; Claes, K. B. M.; Hebrant, A.; Van der Meulen, J.; Delafontaine, B.; Vanden Bempt, I; Maetens, J.; de Hemptinne, M.; Rottey, S.; Aftimos, P.; De Greve, J. | Journal Contribution | A1 |
| 13 | 2022 | Photobiomodulation therapy for the management of chemotherapy-induced alopecia: Preliminary results of a randomized, controlled trial | LODEWIJCKX, Joy; ROBIJNS, Jolien; CLAES, Marithe; MEBIS, Jeroen | Journal Contribution | M |
| 14 | 2022 | Photobiomodulation therapy for the prevention of chemotherapy-induced peripheral neuropathy (NEUROLASER trial) | LODEWIJCKX, Joy; ROBIJNS, Jolien; CLAES, Marithe; Hermans, S.; MEBIS, Jeroen | Journal Contribution | M |
| 15 | 2022 | The use of photobiomodulation therapy for the prevention of chemotherapy-induced peripheral neuropathy: a randomized, placebo-controlled pilot trial (NEUROLASER trial) | LODEWIJCKX, Joy; ROBIJNS, Jolien; CLAES, Marithe; Evens, Stijn; Swinnen, Laura; Lenders, Hilde; Bortels, Sandra; Nassen, Wendy; Hilkens, Ruth; Raymakers, Liesbeth; Snoekx, Sylvana; Hermans, Sylvia; MEBIS, Jeroen | Journal Contribution | A1 |
| 16 | 2022 | Photobiomodulation Therapy in Management of Cancer Therapy-Induced Side Effects: WALT Position Paper 2022 | ROBIJNS, Jolien; LODEWIJCKX, Joy; Arany, Praveen; Barasch, Andrei; Jan, Bjordal; Bossi, Paolo; Chilles, Anne; Corby, Patricia; Epstein, Joel; Elad, Sharon; Fekrazad, Reza; Fregnani, Eduardo; Genot, Marie-Thérèse; Ibarra, Ana; Hamblin, Michael; Heiskanen, Vladimir; Hu, Ken; Klastersky, Jean; Lalla, Raj; Latifian, Sofia; Maiya, Arun; MEBIS, Jeroen; Migliorati, Cesar; Milstein, Dan; Murhpy, Barbara; Raber-Durlacher, Judith; Roseboom, Hendrik; Sonis, Stephen; Treister, Nathaniel; Zadik, Yehuda; Bensadoun, René-Jean | Journal Contribution | A1 |
| 17 | 2022 | Response to the Comment on "Photobiomodulation therapy for the prevention of acute radiation dermatitis (RD) in head and neck cancer patients (DERMIS- HEAD trial)" by He et al | ROBIJNS, Jolien; LODEWIJCKX, Joy; Claes , Stefan; Van Bever, Leen; Pannekoeke , Luc; Censabella, Sandrine; Busse, Lore; COLSON, Dora; Kaminski, Iris; Broux, Victoria; Puts , Sofie; Vanmechelen, Sofie; Timmermans, An; Noe, Leen; BULENS, Paul; Govers, Mieke; Maes, Annelies; MEBIS, Jeroen | Journal Contribution | A1 |
| 18 | 2022 | A long‐term follow‐up of early breast cancer patients treated with photobiomodulation during conventional fractionation radiotherapy in the prevention of acute radiation dermatitis | ROBIJNS, Jolien; LODEWIJCKX, Joy; CLAES, Marithe; Lenaerts, Melissa; Van Bever, Leen; Claes, Stefan; Pannekoeke, Luc; Verboven, Katleen; Noé, Leen; MAES, Annelies; BULENS, Paul; MEBIS, Jeroen | Journal Contribution | A1 |
| 19 | 2022 | Photobiomodulation therapy for the prevention of acute radiation dermatitis in breast cancer patients undergoing hypofractioned whole‐breast irradiation (LABRA trial) | ROBIJNS, Jolien; LODEWIJCKX, Joy; Van Bever, Leen; Puts, Sofie; Timmermans, An; Noe, Leen; Vanmechelen, Sofie; Govers, Mieke; Van de Werf, Evelyn; MAES, Annelies; BULENS, Paul; MEBIS, Jeroen; Claes, Stefan; Pannekoeke, Luc | Journal Contribution | A1 |
| 20 | 2022 | The perspective of patients on the use of telemedicine in cardiovascular care | Knaepen, L.; Essarti, H.; Vervoort, Y.; Driesen , K.; MEBIS, Jeroen; Vandenberk, F.; Vanoppen, A.; DENDALE, Paul; DESTEGHE, Lien; HEIDBUCHEL, Hein | Journal Contribution | M |
Loading...
5
0
5
0
false